Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?

doi:10.4254/wjh.v4.i11.291

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3360)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

344

HTML

2737

Figures (1-1)

117

Tables (1-5)

162

Sum=3360

Nov 27, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Hepatol. Nov 27, 2012; 4(11): 291-298
Published online Nov 27, 2012. doi: 10.4254/wjh.v4.i11.291

Table 1 Clinical characteristics, demographic data and laboratory data of 3857 cirrhotic patients

Parameter	All patients (n = 3857)	Survivors (n = 2375)	Non-survivors (n = 1482)	P value
Age, yr	60.73 ± 14.05	59.02 ± 14.02	63.48 ± 13.65	< 0.001
Male, n (%)	2665 (69.1)	1651 (69.52)	1014 (68.42)	NS (0.474)
Hepatoma, n (%)	1385 (35.9)	653 (27.5)	732 (49.4)	< 0.001
Cause of liver cirrhosis, n (%)				< 0.001
Hepatitis C	930 (24.1)	568 (23.9)	362 (24.4)	-
Hepatitis B	1090 (28.3)	631 (26.6)	459 (31)	-
Alcoholic	813 (21.1)	580 (24.4)	233 (15.7)	-
Hepatitis C + hepatitis B	106 (2.7)	70 (2.9)	36 (2.4)	-
Hepatitis C + alcohol	60 (1.6)	39 (1.6)	21 (1.4)	-
Hepatitis B + alcohol	191 (5)	127 (5.3)	64 (4.3)	-
Hepatitis C + hepatitis B + alcohol	33 (0.9)	19 (0.8)	14 (0.9)	-
Not hepatitis C, hepatitis B or alcohol	634 (16.4)	341 (14.4)	293 (19.8)	-
Ascites, n (%)	1861 (48.2)	825 (34.7)	1036 (69.9)	< 0.001
Hepatic encephalopathy, n (%)	1097 (28.4)	434 (18.3)	663 (44.7)	< 0.001
Child–Pugh points	8.36 ± 2.57	7.11 ± 1.97	10.37 ± 2.1	< 0.001
MELD score	18.9 ± 10.26	13.15 ± 5.57	27.98 ± 9.36	< 0.001
Albumin, 3.5-5 g/dL	2.95 ± 0.73	3.24 ± 0.68	2.49 ± 0.55	< 0.001
Total bilirubin, 0.3-1.2 mg/dL	5.18 ± 8.16	2.24 ± 3.57	9.89 ± 10.81	< 0.001
INR	1.89 ± 1.75	1.43 ± 0.43	2.72 ± 2.55	< 0.001
BUN, 8-12 mg/dL	34.47 ± 35.55	17.63 ± 15.52	61.44 ± 41.49	< 0.001
Creatinine, 0.4-1.2 mg/dL	1.94 ± 1.91	1.27 ± 1.35	3.01 ± 2.17	< 0.001
eGFR, mL/(min∙1.73 m^-2) (MDRD-4)	63.17 ± 46.12	79.14 ± 37.4	37.57 ± 47.24	< 0.001
eGFR, mL/(min∙1.73 m^-2) (MDRD-6)	54.87 ± 38.25	70.85 ± 33.29	29.32 ± 31.16	< 0.001
eGFR, mL/(min∙1.73 m^-2) (CKD-EPI)	65.39 ± 37.49	82.11 ± 30.28	38.59 ± 31.99	< 0.001

Values were expressed as mean ± SD unless otherwise defined. Statistical comparison was performed with Student’s t and χ² test. MELD: Model for end-stage liver disease; INR: International normalized ratio; BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; MDRD: Modification of diet in renal disease; MDRD-4: 4-variable MDRD; MDRD-6: 6-variable MDRD; CKD-EPI: The chronic kidney disease epidemiology collaboration; NS: Not significant.

Citation: Chen YW, Chang CW, Chang CW, Wang TE, Wu CJ, Chen HH. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 2012; 4(11): 291-298
URL: https://www.wjgnet.com/1948-5182/full/v4/i11/291.htm
DOI: https://dx.doi.org/10.4254/wjh.v4.i11.291